REGINA SHEARS-MCCLOUD: Open Payments
NPI 1700322781 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 16 payments from 10 companies in 2025. Trend: 2023 $150 · 2024 $0 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $220 |
| Abbott Laboratories | 2 | $213 |
| Novo Nordisk Inc | 3 | $167 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 2 | $124 |
| ABBVIE INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: DEXCOM G7 GSS (161), Ozempic, FREESTYLE LIBRE 3, Qelbree, SHINGRIX, FREESTYLE LIBRE 2, Dexcom G6 Transmitter, Kerendia.
Industry payments across FL — which companies pay providers there.
